Author:
van Doorn R.,Akkooi A. C. J.,van Dijk M. R.,Haanen J. B. A. G.
Reference19 articles.
1. Cameron MC, Lee E, Hibler BP, Giordano CN, Barker CA, Mori S, et al. Basal cell carcinoma: contemporary approaches to diagnosis, treatment, and prevention. J Am Acad Dermatol. 2019;80(2):321–39.
2. Elder DE, Massi D, Scolyer R, Willemze R. WHO classification of skin tumours (4th edition). WHO classification of tumors. 2019;11.
3. Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017 Jun 8;376(23):2211–22.
4. Franke V, Berger DMS, Klop WMC, Van der Hiel B, Van de Wiel BA, Ter Meulen S, et al. High response rates for T-VEC in early metastatic melanoma (stage IIIB/C-IVM1a). Int J Cancer. 2019 Aug 15;145(4):974–8.
5. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Zanetti R, Masini C, et al. Meta-analysis of risk factors for cutaneous melanoma III: family history, actinic damage and phenotypic factors. Eur J Cancer. 2005;41:2040–59.